Index RUT
P/E 15.54
EPS (ttm) 2.11
Insider Own 21.90%
Shs Outstand 128.37M
Perf Week 15.37%
Market Cap 4.26B
Forward P/E 14.56
EPS next Y 2.25
Insider Trans -1.21%
Shs Float 101.56M
Perf Month 10.05%
Income 259.97M
PEG 0.49
EPS next Q 0.61
Inst Own 76.69%
Short Float 2.24%
Perf Quarter 24.73%
Sales 6.79B
P/S 0.63
EPS this Y 4.85%
Inst Trans -3.27%
Short Ratio 4.17
Perf Half Y 46.71%
Book/sh 10.65
P/B 3.07
EPS next Y 7.77%
ROA 3.34%
Short Interest 2.28M
Perf Year 6.44%
Cash/sh 0.71
P/C 45.95
EPS next 5Y 31.82%
ROE 20.49%
52W Range 21.28 - 33.51
Perf YTD 39.28%
Dividend Est. 0.33 (1.02%)
P/FCF 17.65
EPS past 5Y 13.25%
ROI 4.23%
52W High -2.33%
Beta 1.42
Dividend TTM 0.50 (1.53%)
Quick Ratio 1.22
Sales past 5Y 5.64%
Gross Margin 11.34%
52W Low 53.81%
ATR (14) 0.87
Dividend Ex-Date May 15, 2024
Current Ratio 1.22
EPS Y/Y TTM 49.84%
Oper. Margin 8.74%
RSI (14) 74.93
Volatility 4.44% 2.94%
Employees 54600
Debt/Eq 3.74
Sales Y/Y TTM 6.08%
Profit Margin 3.83%
Recom 1.40
Target Price 35.80
Option/Short Yes / Yes
LT Debt/Eq 3.49
EPS Q/Q 35.58%
Payout 26.22%
Rel Volume 1.06
Prev Close 32.11
Sales Surprise 2.90%
EPS Surprise 35.66%
Sales Q/Q 7.44%
Earnings May 02 AMC
Avg Volume 546.18K
Price 32.73
SMA20 16.15%
SMA50 15.01%
SMA200 23.85%
Trades
Volume 577,706
Change 1.93%
Date
Action
Analyst
Rating Change
Price Target Change
May-13-21 Reiterated
The Benchmark Company
Buy
$40 → $44
Feb-26-21 Upgrade
BofA Securities
Underperform → Buy
$30 → $36
Jun-16-20 Downgrade
BofA/Merrill
Neutral → Underperform
$18 → $15
Sep-17-19 Initiated
Deutsche Bank
Buy
$22
May-17-19 Upgrade
JMP Securities
Mkt Perform → Mkt Outperform
$18
Dec-14-18 Initiated
Barclays
Equal Weight
Oct-16-18 Initiated
Credit Suisse
Neutral
$18
Feb-27-18 Upgrade
JMP Securities
Mkt Underperform → Mkt Perform
Jan-30-18 Resumed
Wells Fargo
Outperform
Jan-04-18 Upgrade
BofA/Merrill
Underperform → Neutral
Aug-07-17 Upgrade
Robert W. Baird
Neutral → Outperform
$15 → $21
Aug-07-17 Reiterated
The Benchmark Company
Buy
$17 → $20
Mar-31-17 Initiated
The Benchmark Company
Buy
$13
Jan-30-17 Downgrade
Wells Fargo
Outperform → Market Perform
Sep-28-16 Downgrade
JMP Securities
Mkt Perform → Mkt Underperform
May-09-16 Reiterated
UBS
Reduce
$8 → $11
Nov-02-15 Reiterated
RBC Capital Mkts
Outperform
$21 → $17
Oct-20-15 Upgrade
JMP Securities
Mkt Underperform → Mkt Perform
Oct-06-15 Upgrade
Wells Fargo
Market Perform → Outperform
Aug-10-15 Reiterated
RBC Capital Mkts
Outperform
$19 → $21
Show Previous Ratings
May-07-24 02:15PM
09:40AM
09:40AM
May-06-24 09:39AM
08:03AM
09:50AM
Loading…
May-04-24 09:50AM
03:06AM
May-03-24 10:32PM
(Thomson Reuters StreetEvents) +10.47%
May-02-24 10:53PM
06:12PM
04:53PM
(Associated Press Finance)
04:30PM
Apr-05-24 08:00AM
Apr-03-24 10:38AM
Mar-19-24 12:09PM
09:44AM
Loading…
Mar-18-24 09:44AM
08:00AM
Feb-27-24 06:16PM
08:24AM
Feb-23-24 11:03PM
(Thomson Reuters StreetEvents) +9.83%
12:22PM
Feb-22-24 05:55PM
05:12PM
04:58PM
(Associated Press Finance)
04:30PM
Feb-20-24 11:42AM
Feb-15-24 10:00AM
Jan-22-24 04:30PM
Jan-06-24 10:20AM
Jan-05-24 09:49AM
11:55AM
Loading…
Jan-04-24 11:55AM
09:50AM
Jan-03-24 04:15PM
Jan-01-24 09:40AM
Dec-07-23 09:40AM
Dec-06-23 10:57PM
Dec-01-23 08:59AM
Nov-07-23 12:26PM
Nov-05-23 01:45PM
Nov-03-23 10:18PM
(Thomson Reuters StreetEvents)
09:08AM
08:08AM
Nov-02-23 06:53PM
06:44PM
(Associated Press Finance)
04:30PM
11:05AM
Oct-26-23 10:02AM
Oct-25-23 09:40AM
Oct-19-23 12:00PM
04:29AM
Oct-18-23 09:40AM
Oct-17-23 08:35AM
06:03AM
Oct-16-23 08:45AM
Oct-13-23 06:27AM
Oct-10-23 06:23AM
Oct-04-23 08:00AM
Oct-02-23 09:40AM
Sep-29-23 08:24AM
07:39AM
Sep-28-23 07:26AM
Sep-19-23 04:51AM
Sep-18-23 12:20PM
Sep-14-23 08:38AM
04:46AM
Sep-13-23 10:06AM
Sep-12-23 01:01AM
Sep-07-23 04:30PM
Aug-31-23 01:44PM
Aug-29-23 08:50AM
Aug-25-23 09:40AM
Aug-24-23 10:05AM
Aug-09-23 06:09AM
Aug-07-23 06:03AM
Aug-05-23 12:13AM
(Thomson Reuters StreetEvents)
Aug-04-23 12:08PM
Aug-03-23 06:44PM
04:30PM
Jul-30-23 08:40AM
Jul-21-23 11:52AM
Jul-19-23 04:15PM
Jul-14-23 11:59AM
Jul-07-23 08:00AM
Jul-05-23 09:24AM
Jun-21-23 08:00PM
Jun-16-23 10:14AM
Jun-06-23 09:54AM
May-12-23 06:12AM
May-08-23 06:02AM
May-06-23 12:41AM
(Thomson Reuters StreetEvents)
May-05-23 10:49AM
May-04-23 07:35PM
06:32PM
04:30PM
Apr-29-23 09:16AM
Apr-27-23 10:03AM
Apr-26-23 08:00PM
Apr-11-23 06:22AM
Apr-07-23 08:00AM
Apr-06-23 12:00PM
Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared for in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offers physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran's healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Apr 08 '24 Sale 29.90 50,000 1,495,000 6,689,668 Apr 10 04:44 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Mar 08 '24 Sale 28.30 50,000 1,415,000 6,739,668 Mar 11 04:43 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Feb 08 '24 Sale 26.00 50,000 1,300,000 6,789,668 Feb 09 04:34 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Jan 08 '24 Sale 26.63 100,000 2,663,000 6,839,668 Jan 09 04:42 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Dec 14 '23 Sale 25.00 100,000 2,500,000 6,939,668 Dec 14 04:57 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Sep 08 '23 Sale 26.82 50,000 1,341,000 7,039,668 Sep 11 04:01 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Aug 08 '23 Sale 29.52 50,000 1,476,000 7,089,668 Aug 09 05:40 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Jul 10 '23 Sale 30.36 50,000 1,518,000 6,889,668 Jul 11 06:43 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Jun 29 '23 Sale 32.00 100,000 3,200,000 1,279,000 Jun 30 05:27 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Jun 21 '23 Sale 30.00 33,967 1,019,010 1,379,000 Jun 22 06:00 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Jun 08 '23 Sale 28.63 50,000 1,431,500 6,939,668 Jun 09 05:13 PM
Index RUT
P/E -
EPS (ttm) -0.73
Insider Own 0.95%
Shs Outstand 84.12M
Perf Week 2.03%
Market Cap 761.29M
Forward P/E 7.15
EPS next Y 1.27
Insider Trans -0.98%
Shs Float 83.32M
Perf Month -4.84%
Income -60.41M
PEG -
EPS next Q 0.33
Inst Own 97.94%
Short Float 5.52%
Perf Quarter -0.55%
Sales 1.99B
P/S 0.38
EPS this Y -2.70%
Inst Trans -2.30%
Short Ratio 6.65
Perf Half Y -8.59%
Book/sh 11.53
P/B 0.78
EPS next Y 3.22%
ROA -2.65%
Short Interest 4.60M
Perf Year -33.89%
Cash/sh 2.11
P/C 4.28
EPS next 5Y -4.58%
ROE -6.94%
52W Range 7.70 - 15.02
Perf YTD -2.69%
Dividend Est. -
P/FCF 5.71
EPS past 5Y -
ROI -3.90%
52W High -39.75%
Beta 1.59
Dividend TTM -
Quick Ratio 1.20
Sales past 5Y -7.30%
Gross Margin 19.32%
52W Low 17.53%
ATR (14) 0.36
Dividend Ex-Date -
Current Ratio 1.38
EPS Y/Y TTM 13.93%
Oper. Margin 7.91%
RSI (14) 47.02
Volatility 5.13% 3.60%
Employees -
Debt/Eq 0.83
Sales Y/Y TTM 1.15%
Profit Margin -3.03%
Recom 3.11
Target Price 9.07
Option/Short Yes / Yes
LT Debt/Eq 0.83
EPS Q/Q -520.47%
Payout -
Rel Volume 2.29
Prev Close 9.28
Sales Surprise -0.57%
EPS Surprise 8.70%
Sales Q/Q -3.39%
Earnings May 07 BMO
Avg Volume 691.81K
Price 9.05
SMA20 -0.96%
SMA50 -1.81%
SMA200 -15.57%
Trades
Volume 1,585,416
Change -2.48%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-27-21 Initiated
SVB Leerink
Mkt Perform
$29
Jun-23-21 Resumed
Stifel
Hold
$30
Oct-19-20 Downgrade
Deutsche Bank
Hold → Sell
$20 → $12
Jan-03-20 Downgrade
Citigroup
Buy → Neutral
$29
Dec-12-19 Upgrade
Stifel
Hold → Buy
$25 → $33
Sep-06-19 Downgrade
BofA/Merrill
Neutral → Underperform
Jan-15-19 Upgrade
Citigroup
Neutral → Buy
Jan-03-19 Initiated
Deutsche Bank
Hold
$34
Nov-16-18 Initiated
UBS
Sell
$37
Sep-24-18 Upgrade
Leerink Partners
Mkt Perform → Outperform
Sep-18-18 Upgrade
BofA/Merrill
Underperform → Neutral
Aug-03-18 Upgrade
Credit Suisse
Neutral → Outperform
Jul-12-18 Initiated
Leerink Partners
Mkt Perform
$50
Mar-27-18 Initiated
Credit Suisse
Neutral
$57
Feb-12-18 Reiterated
Mizuho
Neutral
$49 → $53
Dec-13-17 Initiated
Piper Jaffray
Overweight
$58
Sep-18-17 Upgrade
KeyBanc Capital Mkts
Sector Weight → Overweight
May-30-17 Reiterated
Mizuho
Neutral
$64 → $58
May-25-17 Reiterated
Stifel
Hold
$65 → $58
May-04-17 Downgrade
BofA/Merrill
Buy → Underperform
Show Previous Ratings
May-07-24 10:54AM
09:30AM
06:00AM
Apr-22-24 06:45AM
Mar-21-24 11:30AM
08:20AM
Loading…
Feb-21-24 08:20AM
Feb-20-24 09:30AM
06:00AM
Feb-15-24 12:13PM
Feb-13-24 06:45AM
Feb-07-24 06:45AM
Nov-16-23 02:20PM
Nov-06-23 09:19AM
Nov-02-23 06:00AM
Oct-26-23 10:02AM
06:45AM
Loading…
Oct-20-23 06:45AM
Aug-29-23 12:07PM
Aug-03-23 06:00AM
Jul-18-23 06:45AM
Jun-21-23 08:00PM
Jun-10-23 09:10AM
May-24-23 09:34AM
May-04-23 04:05PM
May-03-23 06:45AM
May-02-23 06:00AM
Apr-27-23 10:03AM
Apr-26-23 08:00PM
10:18AM
06:45AM
Mar-20-23 10:39AM
05:36PM
Loading…
Mar-08-23 05:36PM
Feb-21-23 06:45AM
Feb-17-23 06:00AM
Feb-10-23 10:00AM
Feb-06-23 06:45AM
Feb-04-23 07:52AM
Jan-01-23 07:31AM
Dec-15-22 07:23PM
(American City Business Journals)
04:41PM
07:25AM
Dec-01-22 06:50AM
Nov-17-22 09:08AM
Nov-07-22 06:45AM
Nov-03-22 06:00AM
Oct-21-22 06:45AM
Oct-13-22 09:40AM
Oct-11-22 07:36AM
Aug-22-22 03:00PM
Aug-04-22 07:35AM
06:00AM
Jul-28-22 10:03AM
Jul-27-22 06:05PM
Jul-24-22 10:08AM
Jul-13-22 06:45AM
Jul-08-22 07:48AM
Jul-05-22 01:55PM
Jun-22-22 09:39AM
Jun-21-22 06:45AM
Jun-08-22 06:45AM
Jun-07-22 10:49AM
May-18-22 06:45AM
May-10-22 11:35AM
May-04-22 06:40AM
Apr-28-22 07:15AM
06:00AM
Apr-25-22 05:25PM
Apr-22-22 09:51AM
(American City Business Journals)
08:55AM
Apr-19-22 06:45AM
Apr-05-22 07:30AM
Mar-31-22 02:35PM
11:05AM
Mar-28-22 11:07AM
Mar-24-22 01:35PM
Mar-22-22 07:30AM
Mar-21-22 01:53PM
Mar-16-22 01:24PM
11:54AM
Mar-11-22 01:54PM
Mar-10-22 09:35AM
Mar-07-22 08:03AM
Mar-03-22 10:46AM
Mar-02-22 05:36PM
07:00AM
Mar-01-22 10:09AM
Feb-25-22 08:45AM
Feb-24-22 07:00AM
Feb-23-22 07:00AM
Feb-18-22 01:57PM
Feb-17-22 03:08PM
(American City Business Journals) -6.06%
08:21AM
07:15AM
06:45AM
06:00AM
Feb-16-22 06:35PM
09:48AM
Feb-15-22 09:27AM
Feb-14-22 12:34PM
06:45AM
Feb-10-22 03:01PM
Pediatrix Medical Group, Inc. engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Swift James D Chief Executive Officer Dec 14 '23 Sale 9.58 5,764 55,219 90,874 Dec 15 05:00 PM Moore Mary Ann E EVP, General Counsel & Sec Dec 14 '23 Sale 9.62 1,150 11,063 15,730 Dec 15 05:00 PM Moore Mary Ann E EVP, General Counsel & Sec Dec 14 '23 Sale 9.62 970 9,331 81,385 Dec 15 05:00 PM Swift James D Chief Executive Officer Jun 14 '23 Sale 14.14 13,193 186,549 96,638 Jun 16 05:00 PM ORDAN MARK S Director May 25 '23 Sale 13.26 33,000 437,580 147,923 May 26 05:00 PM Weis Shirley A Director May 19 '23 Sale 13.63 1,007 13,725 17,668 May 22 05:00 PM Weis Shirley A Director May 18 '23 Sale 13.55 17,993 243,805 18,675 May 22 05:00 PM
Index -
P/E 23.15
EPS (ttm) 3.71
Insider Own 1.55%
Shs Outstand 100.25M
Perf Week 3.00%
Market Cap 8.65B
Forward P/E 18.76
EPS next Y 4.58
Insider Trans -4.22%
Shs Float 99.13M
Perf Month 4.34%
Income 375.40M
PEG 1.57
EPS next Q 1.01
Inst Own 98.49%
Short Float 2.22%
Perf Quarter 18.96%
Sales 4.96B
P/S 1.74
EPS this Y 12.52%
Inst Trans 3.18%
Short Ratio 3.09
Perf Half Y 34.04%
Book/sh 17.30
P/B 4.96
EPS next Y 11.79%
ROA 6.47%
Short Interest 2.20M
Perf Year 37.50%
Cash/sh 2.84
P/C 30.27
EPS next 5Y 14.74%
ROE 24.81%
52W Range 57.55 - 85.84
Perf YTD 28.72%
Dividend Est. 0.60 (0.70%)
P/FCF 36.67
EPS past 5Y 3.48%
ROI 8.14%
52W High 0.05%
Beta 0.92
Dividend TTM 0.60 (0.70%)
Quick Ratio 1.37
Sales past 5Y 2.74%
Gross Margin 19.55%
52W Low 49.23%
ATR (14) 1.63
Dividend Ex-Date Jul 01, 2024
Current Ratio 1.37
EPS Y/Y TTM 38.78%
Oper. Margin 15.35%
RSI (14) 70.25
Volatility 1.68% 1.89%
Employees 37761
Debt/Eq 1.68
Sales Y/Y TTM 5.07%
Profit Margin 7.57%
Recom 1.25
Target Price 94.91
Option/Short Yes / Yes
LT Debt/Eq 1.65
EPS Q/Q 26.65%
Payout 17.27%
Rel Volume 1.36
Prev Close 84.51
Sales Surprise 3.39%
EPS Surprise 19.49%
Sales Q/Q 13.41%
Earnings Apr 24 AMC
Avg Volume 713.72K
Price 85.88
SMA20 5.01%
SMA50 8.45%
SMA200 21.48%
Trades
Volume 973,784
Change 1.62%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated
Barclays
Overweight
$95
Mar-14-23 Initiated
Barclays
Equal Weight
$57
Sep-24-21 Initiated
UBS
Buy
$98
Aug-02-21 Upgrade
Raymond James
Outperform → Strong Buy
$95 → $107
Nov-23-20 Upgrade
Barclays
Equal Weight → Overweight
$96
Aug-20-20 Resumed
Barclays
Equal Weight
$71
Dec-11-19 Downgrade
Wells Fargo
Market Perform → Underperform
Oct-22-19 Resumed
Stephens
Overweight
Sep-17-19 Initiated
Deutsche Bank
Hold
$70
Sep-06-19 Upgrade
BofA/Merrill
Neutral → Buy
$73
Jun-27-19 Initiated
BMO Capital Markets
Outperform
$72
May-30-19 Upgrade
Barclays
Equal Weight → Overweight
Dec-20-18 Initiated
Jefferies
Buy
Dec-14-18 Initiated
Barclays
Equal Weight
Nov-16-18 Initiated
UBS
Buy
$86
Jul-26-18 Upgrade
Piper Jaffray
Neutral → Overweight
Mar-29-18 Resumed
Mizuho
Buy
$62
Jan-30-18 Resumed
Wells Fargo
Market Perform
Show Previous Ratings
May-07-24 04:30PM
03:00PM
03:00PM
11:51AM
May-06-24 05:16PM
09:47AM
Loading…
May-02-24 09:47AM
09:40AM
May-01-24 04:29PM
11:51AM
Apr-30-24 12:17PM
Apr-29-24 12:08PM
09:13AM
Apr-26-24 09:50AM
09:15AM
03:15AM
12:10AM
Loading…
12:10AM
(Thomson Reuters StreetEvents)
Apr-25-24 09:45AM
Apr-24-24 07:00PM
05:52PM
05:30PM
04:44PM
(Associated Press Finance)
04:15PM
Apr-23-24 09:15AM
Apr-22-24 01:31PM
Apr-16-24 09:40AM
Apr-10-24 04:30PM
Apr-04-24 01:37PM
Apr-03-24 04:30PM
09:45AM
Apr-02-24 04:30PM
04:30PM
Loading…
Mar-27-24 04:30PM
09:40AM
Mar-18-24 09:45AM
Mar-15-24 12:46PM
Mar-12-24 11:11AM
Mar-11-24 12:46PM
09:40AM
Mar-10-24 08:38AM
Mar-08-24 11:30AM
Mar-07-24 07:54AM
Mar-05-24 07:45AM
Feb-28-24 09:19AM
Feb-27-24 12:00PM
09:40AM
Feb-23-24 09:40AM
Feb-15-24 04:30PM
Feb-14-24 09:50AM
Feb-09-24 09:13AM
04:31AM
(Thomson Reuters StreetEvents)
Feb-08-24 01:02PM
Feb-07-24 07:30PM
05:10PM
(Associated Press Finance)
04:56PM
04:30PM
Feb-05-24 04:00PM
11:23AM
Jan-29-24 09:15AM
Jan-25-24 09:40AM
Jan-10-24 04:30PM
Dec-27-23 11:44AM
Dec-21-23 01:00AM
Dec-19-23 09:50AM
Dec-18-23 09:50AM
Dec-01-23 09:40AM
Nov-29-23 09:50AM
Nov-27-23 08:30AM
Nov-24-23 02:04PM
Nov-16-23 11:49AM
Nov-15-23 12:39PM
11:45AM
Nov-14-23 02:30PM
Nov-13-23 09:40AM
Oct-31-23 09:55AM
Oct-30-23 11:52AM
09:35AM
Oct-28-23 12:50PM
12:27AM
(Thomson Reuters StreetEvents)
Oct-27-23 12:03PM
Oct-26-23 07:30PM
06:12PM
06:05PM
05:00PM
(Associated Press Finance)
04:32PM
09:40AM
Oct-25-23 06:50PM
Oct-24-23 07:25AM
Oct-19-23 10:01AM
08:50AM
Oct-12-23 09:40AM
Oct-06-23 10:30AM
Oct-03-23 05:43AM
Sep-29-23 02:10PM
Sep-28-23 08:26PM
Sep-25-23 09:40AM
Sep-20-23 01:45PM
09:40AM
Sep-19-23 11:09AM
Sep-15-23 09:00AM
(American City Business Journals)
Sep-13-23 01:26PM
12:05PM
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Darby John Patrick EVP, Gen Counsel & Secretary May 06 '24 Option Exercise 29.06 14,543 422,620 99,316 May 07 11:48 AM Darby John Patrick EVP, Gen Counsel & Secretary May 06 '24 Sale 83.94 14,543 1,220,739 84,773 May 07 11:48 AM CARMICHAEL GREG D Director May 03 '24 Buy 83.73 2,000 167,460 17,050 May 07 11:44 AM Tarr Mark J President & CEO Apr 30 '24 Option Exercise 31.99 44,976 1,438,747 599,074 May 01 11:47 AM Tarr Mark J President & CEO Apr 30 '24 Sale 83.27 44,976 3,745,152 554,098 May 01 11:47 AM COLTHARP DOUGLAS E EVP & Chief Financial Officer Nov 13 '23 Option Exercise 26.55 16,623 441,341 127,508 Nov 14 11:30 AM COLTHARP DOUGLAS E EVP & Chief Financial Officer Nov 13 '23 Sale 63.39 11,215 710,919 116,293 Nov 14 11:30 AM Charbonneau Elissa Joy Chief Medical Officer Aug 17 '23 Sale 69.58 8,294 577,097 23,081 Aug 18 11:41 AM Tarr Mark J President & CEO Aug 16 '23 Option Exercise 26.55 25,330 672,512 522,735 Aug 17 08:44 PM Tarr Mark J President & CEO Aug 16 '23 Sale 71.06 25,330 1,799,950 497,405 Aug 17 08:44 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite